Activity, Safety and Pharmacokinetics in Pediatric Subjects With Moderate and Severe Chronic Graft vs. Host Disease After Allogeneic Stem Cell Transplant
Clinical trial NCT03774082 · COMPLETED
Trial details
- NCT number
- NCT03774082
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-20
- Primary completion
- 2022-02-25
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.